(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of -0.65% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 5.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.
Embecta's revenue in 2023 is $1,120,800,000.On average, 1 Wall Street analysts forecast EMBC's revenue for 2024 to be $63,069,803,139, with the lowest EMBC revenue forecast at $63,069,803,139, and the highest EMBC revenue forecast at $63,069,803,139.
In 2025, EMBC is forecast to generate $63,431,584,597 in revenue, with the lowest revenue forecast at $63,431,584,597 and the highest revenue forecast at $63,431,584,597.